OASMY
Price:
$0.0001
Market Cap:
$48.15M
Vivesto AB, a pharmaceutical enterprise founded in 1988 and headquartered in Solna, Sweden, is dedicated to the research, manufacturing, marketing, and distribution of medications for both human and animal oncology, primarily serving the Swedish market. Its flagship human medicine is Apealea, a paclitaxel micellar drug prescribed for the treatment of ovarian cancer. The company's human health pipeline further includes Docetaxel micellar, a unique patented formulation combining the cytotoxin docetaxel with XR-17, which is currently undergoing Phase 1b clinical trials for prostate cancer, as well as Cantrixil, another therapeutic option for ovarian cancer. In the animal health sector, Vivesto ...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2015-10-23
Stock Exchange
OTC
Ticker
OASMY
According to Vivesto AB’s latest financial reports and current stock price. The company's current ROE is -23.13%. This represents a change of 292.29% compared to the average of -5.89% of the last 4 quarters.
The mean historical ROE of Vivesto AB over the last ten years is -36.22%. The current -23.13% ROE has changed -36.16% with respect to the historical average. Over the past ten years (40 quarters), OASMY's ROE was at its highest in in the December 2020 quarter at 17.83%. The ROE was at its lowest in in the December 2022 quarter at -66.80%.
Average
-36.22%
Median
-30.78%
Minimum
-112.79%
Maximum
0.86%
Discovering the peaks and valleys of Vivesto AB ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 346.22%
Maximum Annual ROE = 0.86%
Minimum Annual Increase = -3036.79%
Minimum Annual ROE = -112.79%
| Year | ROE | Change |
|---|---|---|
| 2025 | -27.36% | 8.96% |
| 2024 | -25.11% | -77.74% |
| 2022 | -112.79% | 346.22% |
| 2021 | -25.28% | -3036.79% |
| 2020 | 0.86% | -166.95% |
| 2020 | -1.29% | -96.81% |
| 2019 | -40.33% | 17.92% |
| 2018 | -34.20% | -35.89% |
| 2017 | -53.35% | 22.90% |
| 2016 | -43.41% | 38.81% |
The current ROE of Vivesto AB (OASMY) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-55.08%
5-year avg
-37.93%
10-year avg
-36.22%
Vivesto AB’s ROE is less than Valeo Pharma Inc. (95.58%), greater than China Health Industries Holdings, Inc. (-1.00%), less than BioQuest Corp. (203.02%), less than Eco-Growth Strategies Inc. (10.69%), greater than Medicure Inc. (-44.51%), greater than Herbal Dispatch Inc. (-111.89%), greater than Noveris Health Sciences Inc. (-14.60%), greater than Red Light Holland Corp. (-29.63%), less than OpGen, Inc. (111.12%), less than Eagle Pharmaceuticals, Inc. (17.39%),
| Company | ROE | Market cap |
|---|---|---|
| 95.58% | $9.87K | |
| -1.00% | $6.55K | |
| 203.02% | $758.02K | |
| 10.69% | $3.17M | |
| -44.51% | $6.99M | |
| -111.89% | $11.67M | |
| -14.60% | $117.10M | |
| -29.63% | $8.51M | |
| 111.12% | $242.67M | |
| 17.39% | $8.09M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vivesto AB using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Vivesto AB or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Vivesto AB's ROE?
How is the ROE calculated for Vivesto AB (OASMY)?
What is the highest ROE for Vivesto AB (OASMY)?
What is the 3-year average ROE for Vivesto AB (OASMY)?
What is the 5-year average ROE for Vivesto AB (OASMY)?
How does the current ROE for Vivesto AB (OASMY) compare to its historical average?